Allergy
Geographic Differences in Dupilumab Treatment Outcomes for Atopic Dermatitis: A Systematic Review and Meta-Regression Analysis.
Shauni De Vriese, Hafsa Belasri, Fariza Mishaal Saiema Badloe, Lize Dimitri Inge De Bauw, Jan Gutermuth, Inge Kortekaas Krohn
Published: 202510.1111/all.70144
Abstract
Dupilumab, a monoclonal antibody targeting interleukins (IL)-4/IL-13 signaling, demonstrated efficacy in clinical trials for atopic dermatitis. However, real-world variability remains underexplored. A systematic review with meta-regression was conduc…
Preview only. Read the full abstract at the source